Day: June 23, 2021

Credicorp announces Gianfranco Ferrari will succeed Walter Bayly as CEO, effective January 2022

Credicorp announces Gianfranco Ferrari will succeed Walter Bayly as CEO, effective January 2022

Lima, June 23, 2021 (GLOBE NEWSWIRE) — Credicorp Ltd. (NYSE: BAP) announces that the Board of Directors, in its session held on June 23rd, 2021, has appointed Gianfranco Ferrari as the new CEO of Credicorp, effective January 2022. Today, Mr. Ferrari is Deputy CEO and Head of Universal Banking, the main Line of Business at Credicorp. Gianfranco Ferrari will succeed Walter Bayly, who decided to retire at the end of 2021 after an extraordinary 28 year career at the Group, including the last three years as CEO of Credicorp and the previous 10 years as CEO of our main subsidiary, Banco de Credito del Peru (BCP). Gianfranco Ferrari, the right person to take the lead“Gianfranco is the right person to guide Credicorp in this new era” – said Luis Romero, Executive Chairman of the Board. “He will run Credicorp, not only because of his outstanding...

Continue reading

Scorpio Tankers Inc. Announces Closing of $61.8 Million Convertible Note Exchange and New Issuance

Scorpio Tankers Inc. Announces Closing of $61.8 Million Convertible Note Exchange and New Issuance

MONACO, June 23, 2021 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”) announced today that it has closed its previously announced private exchange offer (the “Exchange Offer”), pursuant to which certain holders of the Company’s 3.00% Convertible Senior Notes due 2022 (the “Existing Notes”) exchanged $19.4 million in aggregate principal amount of such Existing Notes for $19.4 million in aggregate principal amount of the Company’s 3.00% Convertible Senior Notes due 2025 (the “Exchange Notes”). In addition, the Company has closed separate, privately negotiated, agreements with certain investors for the sale (the “Sale”) of $42.4 million in aggregate principal amount of the new 3.00% Convertible Senior Notes due 2025 (the “Purchased Notes” at 102.25% of par, plus accrued interest from May 15,...

Continue reading

GENFIT presents new NIS4® data in NASH at the International Liver Congress™ and the 81st Scientific Sessions of the American Diabetes Association

GENFIT presents new NIS4® data in NASH at the International Liver Congress™ and the 81st Scientific Sessions of the American Diabetes Association

Study highlights the clinical performance of NIS4® technology in diagnosing at-risk NASH in patients with type 2 diabetes irrespective of age compared to other non-invasive tests New analyses show the potential of NIS4® technology to be a valuable clinical tool either alone or in sequential combination with other blood-based non-invasive tests in identifying at-risk NASH and advanced fibrosis in patients with and without type 2 diabetes   Key Opinion Leaders highlight the potential for non-invasive tests in the diagnosis of at-risk NASH on ADA TV Lille, France; Cambridge, MA; June 23, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, today announced it will be making two poster presentations at two internationally-renown...

Continue reading

Motus GI Appoints Experienced Financial Biotech Executive, Sonja Nelson, to its Board of Directors and as Chair of Audit Committee

Motus GI Appoints Experienced Financial Biotech Executive, Sonja Nelson, to its Board of Directors and as Chair of Audit Committee

FORT LAUDERDALE, Fla., June 23, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced the appointment of Sonja Nelson, CPA to the Company’s Board of Directors and as Chair of the Audit Committee. Ms. Nelson brings more than 25 years of financial and operational leadership and expertise in biotechnology, diagnostics, and biopharmaceuticals markets, including playing an integral role in the successful merger between NantKwest, Inc. (Nasdaq: NK) and Immunity Bio, Inc. (Nasdaq: IBRX). “We are thrilled to welcome Sonja to our Board of Directors,” commented...

Continue reading

Highwoods Sells Non-Core Asset in Tampa for $43.0M

Highwoods Sells Non-Core Asset in Tampa for $43.0M

RALEIGH, N.C., June 23, 2021 (GLOBE NEWSWIRE) — Highwoods Properties, Inc. (NYSE:HIW) has sold Preserve VII, a 115,000 square foot single customer building in north Tampa, for $43.0 million. This property is 100% occupied and is projected to generate $2.0 million of annual cash net operating income, including the impact of $0.4 million of free rent, and $2.4 million of annual GAAP net operating income in 2021. The Company expects to record a non-FFO gain of approximately $22.8 million in the second quarter of 2021 in connection with this sale. Ted Klinck, President and Chief Executive Officer of Highwoods Properties, said, “This sale is the first closing in our plan to substantially fund our planned portfolio acquisition from PAC with proceeds from non-core asset sales. We are pleased with the execution of this sale and buyer interest...

Continue reading

Pacific Biosciences and Rady Children’s Institute for Genomic Medicine Announce  its First Research Collaboration for Whole Genome Sequencing

Pacific Biosciences and Rady Children’s Institute for Genomic Medicine Announce its First Research Collaboration for Whole Genome Sequencing

HiFi Sequencing will be used on a cohort of rare disease cases with the aim to identify numerous variants, both small and structural, that are not readily detectable by short-read sequencing MENLO PARK, Calif., June 23, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, and Rady Children’s Institute for Genomic Medicine (RCIGM), a mission-driven, non-profit seeking to save lives and improve outcomes for patients, clinicians and families, shared today that they are collaborating on a study which aims to identify potential disease-causing genetic variants and increase the solve rates of rare diseases. The study is focused on long-read whole genome sequencing of rare disease cases for which previous short-read...

Continue reading

Steelcase Reports First Quarter Fiscal 2022 Results

Steelcase Reports First Quarter Fiscal 2022 Results

Orders grew 11% compared to prior year and 25% compared to fourth quarter, reflecting momentum as companies plan to return to the office Revenue increased 15% compared to prior year, with broad-based growth across all segments Price increases expected to begin offsetting significant inflationary pressures later in fiscal year Outlook for second quarter and remainder of year expects strengthening recovery driven by reopening of offices Dividend restored to pre-pandemic level of $0.145 per share GRAND RAPIDS, Mich., June 23, 2021 (GLOBE NEWSWIRE) — Steelcase Inc. (NYSE: SCS) today reported first quarter revenue of $556.6 million and a net loss of $28.1 million, or $0.24 per share. In the prior year, Steelcase reported revenue of $482.8 million and a net loss of $38.1 million, or $0.33 per share and an adjusted loss of $0.18 per...

Continue reading

Vanguard Announces Cash Distributions for the Vanguard ETFs

Vanguard Announces Cash Distributions for the Vanguard ETFs

(VAB, VSB, VSC, VLB, VCB, VGV, VRIF, VRE, VDY, VCE, VCN, VE, VIU, VI, VIDY, VA, VCNS, VBAL, VGRO and VCIP) TORONTO , June 23, 2021 (GLOBE NEWSWIRE) — Vanguard Investments Canada Inc. today announced the final June 2021 cash distributions for certain Vanguard ETFs, listed below, that trade on Toronto Stock Exchange (TSX). Unitholders of record on July 02, 2021 will receive cash distributions payable on July 09, 2021. Details of the “per unit” distribution amounts are as follows:   Vanguard ETF® TSX TickerSymbol Distributionper Unit ($) CUSIP ISIN PaymentFrequency Vanguard Canadian Aggregate Bond Index ETF VAB 0.059347 92203E101 CA92203E1016 Monthly Vanguard Canadian Short-Term Bond Index ETF VSB 0.043312 92203G106 CA92203G1063 Monthly Vanguard Canadian Short-Term Corporate Bond Index ETF VSC 0.055187 92203N101 CA92203N1015 Monthly Vanguard...

Continue reading

Nouveau Monde Announces Closing of US$59.4 Million Public Offering of Common Shares in the United States and Canada

Nouveau Monde Announces Closing of US$59.4 Million Public Offering of Common Shares in the United States and Canada

MONTREAL, June 23, 2021 (GLOBE NEWSWIRE) — Nouveau Monde Graphite Inc. (“Nouveau Monde” or the “Company”) (NYSE: NMG; TSXV: NOU) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 7,915,000 of its common shares (the “Common Shares”), which includes the partial exercise by the underwriters of their option to purchase additional Common Shares, at a price per share of US$7.50 (the “Offering Price”) for aggregate gross proceeds of US$59,362,500. Evercore ISI and BMO Capital Markets acted as joint book-running managers for the Offering. B. Riley Securities and Stifel GMP also acted as joint book-running managers. Roth Capital Partners acted as co-manager for the Offering. One of the Company’s current shareholders, Pallinghurst Graphite International Limited, through its subsidiary...

Continue reading

IBC Advanced Alloys Announces Closing of its Non-Brokered Private Placement

IBC Advanced Alloys Announces Closing of its Non-Brokered Private Placement

[NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR FOR DISSEMINATION IN THE UNITED STATES] FRANKLIN, Ind., June 23, 2021 (GLOBE NEWSWIRE) — IBC Advanced Alloys Corp. (“IBC” or the “Company”) (TSX-V: IB; OTCQB: IAALF) is pleased to announce that it has closed the Company’s previously announced non-brokered private placement (the “Offering”). Pursuant to the Offering, the Company issued 10,270,224 units of the Company (the “Units“) at a price of C$0.20 per Unit for gross proceeds to the Company of approximately C$2,054,000. Each Unit consists of one common share of IBC (each, a “Common Share“) and one common share purchase warrant (a “Warrant“). Each Warrant will entitle the holder to acquire one common share of the Company at a price of C$0.23 until June 23, 2023. All of the securities issued pursuant...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.